Standout Papers

Epidermal growth factor receptor mutations in lung cancer 2004 2026 2011 2018 2.4k
  1. Epidermal growth factor receptor mutations in lung cancer (2007)
    Sreenath V. Sharma, Daphne W. Bell et al. Nature reviews. Cancer
  2. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK (2009)
    Alice T. Shaw, Beow Y. Yeap et al. Journal of Clinical Oncology
  3. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways (2004)
    Raffaella Sordella, Daphne W. Bell et al. Science
  4. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells (2008)
    Shyamala Maheswaran, Lecia V. Sequist et al. New England Journal of Medicine
  5. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib (2005)
    Eunice L. Kwak, Raffaella Sordella et al. Proceedings of the National Academy of Sciences
  6. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 (1993)
    Xianfeng Zhang, Jeffrey Settleman et al. Nature
  7. EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib (2012)
    Ryan B. Corcoran, Hiromichi Ebi et al. Cancer Discovery
  8. First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations (2008)
    Lecia V. Sequist, Renato Martins et al. Journal of Clinical Oncology
  9. SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction (2011)
    Hiroyuki Inuzuka, Shavali Shaik et al. Nature

Immediate Impact

4 by Nobel laureates 62 from Science/Nature 164 standout
Sub-graph 1 of 16

Citing Papers

Early detection of cancer
2022 StandoutScience
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
2020 StandoutNature
40 intermediate papers

Works of Jeffrey Settleman being referenced

TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF- Mutant Melanoma
2013
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
2012 Standout
and 25 more

Author Peers

Author Last Decade Papers Cites
Jeffrey Settleman 13871 10236 3630 7598 158 23.2k
Patricia S. Steeg 13074 8285 1590 5165 198 22.7k
Michael J. Eck 18019 12335 3400 11015 156 32.0k
Dennis C. Sgroi 10910 8548 2152 2766 172 20.7k
Jeffrey A. Engelman 20979 15823 4560 13540 181 35.4k
Yibin Kang 15426 10980 1749 2615 187 24.7k
Arul M. Chinnaiyan 13986 3652 2561 8679 110 21.7k
Jeremy A. Squire 18211 13137 2173 8023 377 33.2k
Levi A. Garraway 14619 6935 1646 3808 172 22.1k
Robert L. Sutherland 10330 7679 1296 3274 236 18.9k
Hong Wu 16440 7083 2108 3303 203 25.8k

All Works

Loading papers...

Rankless by CCL
2026